Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Classification and Regression Trees.

Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858

Classification and Regression Trees.

Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030

Cancer Statistics, 2008

Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184

Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548

A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031

An Introduction to Recursive Partitioning Using the RPART Routines

Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531

Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases

Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

Li, J., Wang, J., Zhai, X., Jia, W., Zhu, H., & Yu, J. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s288928 · Cited by 15

Radionecrosis (RN) in patients with brain metastases treated with stereotactic radiosurgery (SRS) and immunotherapy

Andring, L. M., Squires, B. S., Seymour, Z., Fahim, D. K., Jacob, J. T., Ye, H., Marvin, K. S., & Grills, I. S. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1900843 · Cited by 15

Brain metastasis: Recent treatment modalities and future‑perspectives (Review)

Katano, A., & Yamashita, H. (2022) · Oncology Letters · doi:10.3892/ol.2022.13311 · Cited by 15

The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases

Siegl, F., Večeřa, M., Rošková, I., Smrčka, M., Jančálek, R., Kazda, T., Slabý, O., & Šáňa, J. (2022) · Cancers · doi:10.3390/cancers14143386 · Cited by 15

Differentiating Primary Tumors for Brain Metastasis with Integrated Radiomics from Multiple Imaging Modalities

Cao, G., Zhang, J., Lei, X., Yu, B., Ai, Y., Zhang, Z., Xie, C., & Jin, X. (2022) · Disease Markers · doi:10.1155/2022/5147085 · Cited by 17

Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications

Honda, Y., Aruga, T., Yamashita, T., Miyamoto, H., Horiguchi, K., Kitagawa, D., Idera, N., Goto, R., & Kuroi, K. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv067 · Cited by 15

The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non–Small Cell Lung Cancer

Hejleh, T. A., Chrischilles, E. A., Halfdanarson, T. R., Simon, C., Pendergast, J., Jiang, D., Smith, C. J., Porter, A. T., Carter, K. D., & Wallace, R. B. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000029 · Cited by 15

Factors associated with long-term survival in central nervous system metastases

Díaz, B. C., Spínola-Maroño, H., González-Aguilar, A., & Arrieta, O. G. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2946-x · Cited by 15

Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases

Yu, X., & Fan, Y. (2019) · Journal of Cancer · doi:10.7150/jca.30292 · Cited by 15

Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast‐GPA 0‐2.0

Ou, D., Cao, L., Xu, C., Kirova, Y., & Chen, J. (2019) · The Breast Journal · doi:10.1111/tbj.13426 · Cited by 15

Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases

Janssen, S., Mehta, P., Bartscht, T., Schmid, S. M., Fahlbusch, F. B., & Rades, D. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1337-6 · Cited by 15

Fundamentals of Radiation Oncology for Neurologic Imaging

Mendel, J., Jaster, A. W., Yu, F. F., Morris, L. C., Lynch, P. T., Shah, B., Agarwal, A. K., Timmerman, R. D., Nedzi, L. A., & Raj, K. M. (2020) · Radiographics · doi:10.1148/rg.2020190138 · Cited by 15

Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases

Chen, K., Zhang, F., Fan, Y., & Cheng, G. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s255478 · Cited by 15

Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non–small cell lung cancer

Cho, A., Hennenberg, J., Untersteiner, H., Hirschmann, D., Gatterbauer, B., Zöchbauer-Müller, S., Hochmair, M. J., Preusser, M., Rössler, K., Dorfer, C., et al. (2022) · Journal of neurosurgery · doi:10.3171/2021.12.jns212193 · Cited by 15

Predicting leptomeningeal disease spread after resection of brain metastases using machine learning

Tewarie, I. A., Senko, A. W., Jessurun, C. A. C., Zhang, A. T., Hulsbergen, A. F. C., Rendón, L. F., McNulty, J. J., Broekman, M. L. D., Peng, L. C., Smith, T. R., et al. (2022) · Journal of neurosurgery · doi:10.3171/2022.8.jns22744 · Cited by 14

Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study

Pikis, S., Mantziaris, G., Protopapa, M., Tos, S. M., Kowalchuk, R. O., Ross, R. B., Rusthoven, C. G., Tripathi, M., Langlois, A.-M., Mathieu, D., et al. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04775-3 · Cited by 14

Outcomes of gamma knife radiosurgery, bi-modality & tri-modality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience

Wang, T. J. C., Saad, S., Qureshi, Y. H., Jani, A., Isaacson, S. R., Sisti, M. B., Bruce, J. N., McKhann, G. M., Lesser, J., Cheng, S. K., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1728-y · Cited by 14

Adaptation de la radiothérapie des métastases cérébrales selon la classification GPA (Graded Prognostic Assessment)

Antoni, D., & Noël, G. (2013) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2013.06.030 · Cited by 14

Clinical application of RapidArc volumetric modulated arc therapy as a component in whole brain radiation therapy for poor prognostic, four or more multiple brain metastases

Lee, S. H., Lee, K. C., Choi, J., Kim, H. Y., Lee, S. H., Sung, K. H., & Kim, Y. (2012) · Radiation Oncology Journal · doi:10.3857/roj.2012.30.2.53 · Cited by 14

Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors

Ferrel, E. A., Roehrig, A., Kaya, E. A., Carlson, J. D., Ling, B., Wagner, A. E., MacKay, A., Call, J. A., Demakas, J. J., Lamoreaux, W. T., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030400 · Cited by 14

Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential

Roy, A., Libard, S., Weishaupt, H., Gustavsson, I., Uhrbom, L., Hesselager, G., Swartling, F. J., Pontén, F., Alafuzoff, I. I., & Tchougounova, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00115 · Cited by 14

Can stress promote the pathophysiology of brain metastases? A critical review of biobehavioral mechanisms

Seiler, A., Sood, A. K., Jenewein, J., & Fagundes, C. P. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.013 · Cited by 14

Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer

Berghoff, A. S., Wippel, C., Starzer, A. M., Ballarini, N. M., Wolpert, F., Bergen, E. S., Wolf, P. S., Steindl, A., Widhalm, G., Gatterbauer, B., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.05.011 · Cited by 14

Pathological Features of Brain Metastases

Tadros, S., & Ray‐Chaudhury, A. (2020) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2020.06.005 · Cited by 14

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases

Sun, C., Zhou, F., Li, X., Zhao, C., Li, W., Li, J., Xiong, A., Yu, J., Gao, G., Wang, Q., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s286600 · Cited by 14

Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects

Uto, M., Torizuka, D., & Mizowaki, T. (2022) · Japanese Journal of Radiology · doi:10.1007/s11604-022-01333-7 · Cited by 14

Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases

Carpenter, D. J., Leng, J. X., Arshad, M., Giles, W., Kirkpatrick, J. P., Floyd, S., Chmura, S. J., Salama, J. K., & Hong, J. C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.10117 · Cited by 14

Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients

Pontoriero, A., Conti, A., Iatì, G., Mondello, S., Aiello, D., Rifatto, C., Risoleti, E., Mazzei, M., Tomasello, F. F., Pergolizzi, S., et al. (2016) · Neurosurgical Review · doi:10.1007/s10143-016-0718-7 · Cited by 14

Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery

Kano, H., Morales-Restrepo, A., Iyer, A., Weiner, G. M., Mousavi, S. H., Kirkwood, J. M., Tarhini, A. A., Flíckinger, J. C., & Lunsford, L. D. (2017) · Journal of neurosurgery · doi:10.3171/2016.9.jns161011 · Cited by 14

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?

Frega, S., Bonanno, L., Guarneri, V., Conte, P., & Pasello, G. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.05.013 · Cited by 14

Treatment of multiple intracranial metastases in radiation oncology: a contemporary review of available technologies

Skourou, C., Hickey, D., Rock, L., Houston, P., Sturt, P., Sullivan, S. O., Faul, C. M., & Paddick, I. (2021) · BJR|Open · doi:10.1259/bjro.20210035 · Cited by 15

Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non‐small cell lung cancer

Li, X., Wang, Y., Wang, J., Zhang, T., Li, Z., Yang, Z., Xing, L., & Yu, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31303 · Cited by 14

Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients

Chen, T., Tang, M., Zhou, Y., Wang, Z., Li, S., Wang, H., Lu, Y., Wang, J., & Shen, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1216852 · Cited by 13

Brain metastasis in de novo stage IV breast cancer

He, Y., Shao, Y., Chen, Q., Liu, C., Zhu, F., & Liu, H. (2023) · The Breast · doi:10.1016/j.breast.2023.07.005 · Cited by 13

Long-term survival in patients with brain metastases—clinical characterization of a rare scenario

Hügel, M., Stöhr, J., Kuhnt, T., Nägler, F., Papsdorf, K., Klagges, S., Hambsch, P. K., Güresir, E., Nicolay, N. H., & Seidel, C. (2023) · Strahlentherapie und Onkologie · doi:10.1007/s00066-023-02123-4 · Cited by 13

Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases

Zhang, K., Zhang, T., Guo, Z., Zhao, F., Li, J., Li, Y., Yang, L., Wu, X., Chen, X., Zhang, W., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11739-9 · Cited by 13

Case Report of Extended Survival and Quality of Life in a Melanoma Patient with Multiple Brain Metastases and Review of Literature

Sperduto, W., King, D. M., Watanabe, Y., Lou, E., & Sperduto, P. W. (2017) · Cureus · doi:10.7759/cureus.1947 · Cited by 13

Risk of Postoperative Performance Status Worsening after Resection of Lesions Involving the Motor Pathway: A Multinomial Logistic Regression Model

Pesce, A., Fraschetti, F., D’Andrea, G., Polli, F. M., Acqui, M., Frati, A., & Raco, A. (2018) · Journal of Neurological Surgery Part A Central European Neurosurgery · doi:10.1055/s-0037-1617756 · Cited by 13

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

Liu, K., Jiang, G., Zhang, A., Li, Z., & Jia, J. (2020) · BMC Cancer · doi:10.1186/s12885-020-6543-y · Cited by 13

Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan

Deguchi, S., Nakasu, Y., Sakaida, T., Akimoto, J., Tanahashi, K., Natsume, A., Takahashi, M., Okuda, T., Asakura, H., Mitsuya, K., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01740-8 · Cited by 13

The Role of Radiation Therapy in the Older Patient

Dohm, A. E., Díaz, R., & Nanda, R. H. (2021) · Current Oncology Reports · doi:10.1007/s11912-020-01000-y · Cited by 13

A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases

Stankiewicz, M. A., Tomasik, B., & Blamek, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-98847-3 · Cited by 13

Radiomics and Deep Learning in Brain Metastases: Current Trends and Roadmap to Future Applications

Park, Y. W., Lee, N., Ahn, S. S., Chang, J. H., & Lee, S. (2021) · Investigative Magnetic Resonance Imaging · doi:10.13104/imri.2021.25.4.266 · Cited by 13

A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases

Shah, A. N., Santa-Maria, C. A., Mukhija, D., Shah, N. C., Kang, A. K., Kumthekar, P., Burdett, K. B., Chandra, S., Chang, J. C., Tsarwhas, D., et al. (2022) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.12.006 · Cited by 13

Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma

Gutenberg, A., Nischwitz, M., Gunawan, B., Enders, C., Jung, K., Bergmann, M., Feiden, W., Egensperger, R., Keyvani, K., Stolke, D., et al. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.05.004 · Cited by 13

Outcomes and Toxicity of Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab

Olson, A. C., Thomas, S. M., Qin, R., Singh, B. P., Salama, J. K., Kirkpatrick, J. P., & Salama, A. K. S. (2016) · Melanoma Management · doi:10.2217/mmt-2016-0004 · Cited by 13

White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study

Berk, B., Nagel, S., Hering, K., Paschke, S., Hoffmann, K., Kortmann, R., Gaudino, C., & Seidel, C. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2235-5 · Cited by 13

Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy

Pessina, F., Navarria, P., Tomatis, S., Cozzi, L., Franzese, C., Guardo, L. D., Ascolese, A. M., Reggiori, G., Franceschini, D., Vecchio, M. D., et al. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.05.131 · Cited by 13

Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung Cancers

Khandekar, M. J., Piotrowska, Z., Willers, H., & Sequist, L. V. D. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0557 · Cited by 13

Central Nervous System Cancers

Nath, S. K., Trifiletti, D. M., Zaorsky, N. G., & Rusthoven, C. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-96809-4_3 · Cited by 14

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto, P. W., Fang, P., Li, J., Breen, W. G., Brown, P. D., Cagney, D. N., Aizer, A. A., Yu, J. B., Chiang, V., Jain, S. K., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.011 · Cited by 13

Seizure prevalence, contributing factors, and prognostic factors in patients with leptomeningeal disease

Zima, L. A., Tulpule, S., Samson, K. K., & Shonka, N. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.032 · Cited by 13

Management of CNS metastases in patients with EGFR mutation-positive NSCLC

Shetty, V. V., & Suresh Babu, M. C. (2019) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_455_19 · Cited by 13

Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion

Qiao, M., Zhao, C., Liu, Q., Wang, Y., Shi, J., Ng, T. L., Zhou, F., Li, X., Jiang, T., Yang, S., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-346 · Cited by 13

Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cM et as a negative prognostic factor

Schiefer, A., Mesteri, I., Berghoff, A. S., Haitel, A., Schmidinger, M., Preusser, M., & Birner, P. (2015) · Histopathology · doi:10.1111/his.12709 · Cited by 13

Brain metastases: fractionated whole-brain radiotherapy

Wang, T. J. C., & Brown, P. D. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-811161-1.00009-8 · Cited by 13

Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases

Ho, K., Toh, C., Li, S., Liu, C., Yang, C., Lin, Y.-J., Su, T.-P., Wang, C., & Yen, T. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4210-1 · Cited by 13

Delirium-related factors and their prognostic value in patients undergoing craniotomy for brain metastasis

Yoo, J., Joo, B., Park, J., Park, H. H., Park, M., Ahn, S. J., Suh, S. H., Kim, J., & Oh, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.988293 · Cited by 12

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review

Nepote, A., Poletto, S., Bertaglia, V., Carnio, S., Piumatti, C., Lanzetta, C., Cantale, O., Saba, G., Bironzo, P., Novello, S., et al. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104540 · Cited by 12

Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases

Chowdhury, I. H., Ojerholm, E., McMillan, M. T., Miller, D., Kolker, J. D., Kurtz, G. A., Dorsey, J. F., Nagda, S. N., Geiger, G. A., Brem, S. S., et al. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0553-y · Cited by 12

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis

Zhao, Q., Qin, Q., Sun, J., Han, D., Wang, Z., Teng, J., & Li, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150419 · Cited by 12

Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients

Díaz, B. C., Spínola-Maroño, H., Mendoza-Olivas, L. G., Monroy-Sosa, A., Soto, G. R., & Arrieta, O. G. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02086-y · Cited by 12

Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery

LeCompte, M. C., Hughes, R. T., Farris, M. K., Masters, A. H., Soike, M. H., Lanier, C. M., Glenn, C. W., Cramer, C. K., Watabe, K., Su, J., et al. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03368-9 · Cited by 12

Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis Patients

Dasgupta, A., Co, J. L., Winter, J. D., Millar, B., Laperrière, N., Tsang, D. S., van Prooijen, M., Damyanovich, A. Z., Heaton, R. K., Coolens, C., et al. (2021) · Current Oncology · doi:10.3390/curroncol28010054 · Cited by 12

Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis

Zimmerman, B. S., Seidman, D., Cascetta, K. P., Ru, M., Moshier, E. L., & Tiersten, A. (2021) · Oncology · doi:10.1159/000512212 · Cited by 12

Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation

Li, C., Nie, W., Guo, J., Xiong, A., Zhong, H., Chu, T., Zhong, R., Xu, J., Lü, J., Zheng, X., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01741-9 · Cited by 12

The association of patient age with postoperative morbidity and mortality following resection of intracranial tumors

Yang, Y., Zeitlberger, A. M., Neidert, M. C., Staartjes, V. E., Broggi, M. A., Zattra, C. M., Vasella, F., Velz, J., Bartek, J. J., Fletcher‐Sandersjöö, A., et al. (2021) · Brain and Spine · doi:10.1016/j.bas.2021.100304 · Cited by 12

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015

Liedtke, C., Thill, M., Hanf, V., & Schütz, F. (2015) · Breast Care · doi:10.1159/000431248 · Cited by 12

Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach

Hulsbergen, A. F. C., Lo, Y. T., Awakimjan, I., Kavouridis, V. K., Phillips, J. G., Smith, T. R., Verhoeff, J. J. C., Yu, K., Broekman, M. L. D., & Arnaout, O. M. (2022) · Neurosurgery · doi:10.1227/neu.0000000000002037 · Cited by 12

Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060

Tozuka, T., Minegishi, Y., Yamaguchi, O., Watanabe, K., Toi, Y., Saito, R., Nagai, Y., Tamura, Y., Shoji, T., Odagiri, H., et al. (2024) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2024.100655 · Cited by 12

DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer

Borm, K. J., Behzadi, S. T., Hörner‐Rieber, J., Krug, D. A., Baumann, R., Corradini, S., Duma, M. N., Dunst, J., Fastner, G., Feyer, P., et al. (2024) · Strahlentherapie und Onkologie · doi:10.1007/s00066-024-02202-0 · Cited by 12

Treatment of Brain Metastases from HER-2-Positive Breast Cancer: Current Status and New Concepts

Bartolotti, M., Franceschi, E., & Brandes, A. A. (2013) · Future Oncology · doi:10.2217/fon.13.90 · Cited by 12

Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy.

Luo, J., Zhu, H., Tang, Y., Wang, H., Zhou, X., Lu, X., Zhang, S., & Li, Y. (2014) · PubMed Central · Cited by 12

A purely functional Imaging based approach for transcortical resection of lesion involving the dominant atrium: Towards safer, imaging-guided, tailored cortico-leucotomies

Frati, A., Pesce, A., D’Andrea, G., Fraschetti, F., Salvati, M., Cimatti, M., Esposito, V., & Raco, A. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.01.045 · Cited by 12

Toward Precision Medicine in Brain Metastases

Berghoff, A. S., & Brastianos, P. K. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1627469 · Cited by 12

Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies

Brastianos, P. K., Ippen, F. M., Hafeez, U., & Gan, H. K. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0614 · Cited by 12

Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors

O'Kane, G. M., & Leighl, N. B. (2018) · CNS Drugs · doi:10.1007/s40263-018-0526-4 · Cited by 12

Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer

Sadraei, N. H., Muller-Greven, G. M., Abdul‐Karim, F. W., Ulasov, I. V., Downs-Kelly, E. P., Burgett, M. E., Lauko, A. J., Qadan, M. A., Weil, R. J., Ahluwalia, M. S., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2959-5 · Cited by 12

Role of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain Metastases

Díaz, B. C., Spínola-Maroño, H., Reynoso, N., González-Aguilar, A., & Mohar, A. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.12.018 · Cited by 12

Safety of resident training in the microsurgical resection of intracranial tumors: Data from a prospective registry of complications and outcome

Vasella, F., Velz, J., Neidert, M. C., Henzi, S., Sarnthein, J., Krayenbühl, N., Bozinov, O., Regli, L., & Stienen, M. N. (2019) · Scientific Reports · doi:10.1038/s41598-018-37533-3 · Cited by 12

Whole Brain Radiotherapy Versus Stereotactic Radiosurgery in Poor-Prognosis Patients with One to 10 Brain Metastases: A Randomised Feasibility Study

Raman, S., Mou, B., Hsu, F., Valev, B., Cheung, A., Vallières, I., Ma, R., McKenzie, M. R., Beaton, L., Rackley, T., et al. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.02.001 · Cited by 12

Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study

Lamba, N., Mehanna, E. K., Kearney, R. B., Catalano, P. J., Brown, P. D., Haas-Kogan, D. A., & Aizer, A. A. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03542-4 · Cited by 12

Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series

Fessart, E., Mouttet-Audouard, R., Tinier, F. L., Coche‐Dequeant, B., Lacornerie, T., Tresch, E., Scherpereel, A., Lartigau, E. F., Mirabel, X., & Pasquier, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-68209-6 · Cited by 12

Surgery for brain metastases – real-world prognostic factors’ association with survival

Winther, R. R., Vik-Mo, E. O., Yri, O. E., Aass, N., Kaasa, S., Skovlund, E., Helseth, E., & Hjermstad, M. J. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1930150 · Cited by 12

Prognostic Factors for Patients With Brain Metastases Treated With Single-fraction Gamma Knife Radiosurgery

Noyama, T., Katano, A., Shinya, Y., Kawashima, M., Shin, M., Saito, N., & Yamashita, H. (2021) · Anticancer Research · doi:10.21873/anticanres.15104 · Cited by 12

Comparative Effectiveness Analysis of Treatment Options for Single Brain Metastasis

Kimmell, K. T., LaSota, E., Weil, R. J., & Marko, N. F. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.06.021 · Cited by 12

Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers

Okon, I. S., Ye, D., Coughlan, K. A., Wang, Q., Song, P., Benbrook, D. M., & Zou, M. (2015) · Oncotarget · doi:10.18632/oncotarget.6699 · Cited by 12

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis

Suzuki, R., Wei, X., Allen, P. K., Welsh, J. W., Cox, J. D., Komaki, R. U., & Lin, S. H. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1205-9 · Cited by 12

Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment

Sperduto, P. W., Marqueen, K. E., Chang, E., Li, J., Davies, M. A., Ebner, D. K., Breen, W. G., Lamba, N., Shih, H. A., Edwards, D. M., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-01351 · Cited by 11

Biological profile of breast cancer brain metastasis

Liu, L., He, Y. Z., Du, H., Tang, M., Wang, T., Tan, J., Zha, L., Yang, L., Ashrafizadeh, M., Tian, Y., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01983-4 · Cited by 11

Comprehensive analysis and validation of contemporary survival prognosticators in Korean patients with metastatic renal cell carcinoma treated with targeted therapy: prognostic impact of pretreatment neutrophil-to-lymphocyte ratio

Koo, K. C., Lee, K. S., Cho, K. S., Rha, K. H., Hong, S. J., & Chung, B. H. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1252-9 · Cited by 11

Fever as a factor contributing to long-term survival in a patient with metastatic melanoma: A case report

Wrotek, S., Brycht, Ł., Wrotek, W., & Kozak, W. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.03.009 · Cited by 11

Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases

Bachmann, N., Leiser, D., Ermiş, E., Vulcu, S., Schucht, P., Raabe, A., Aebersold, D., & Herrmann, E. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1252-x · Cited by 11

Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies

Chang, X., Liu, Z., Man, S., Roys, A., Li, Z., Zuo, D., & Wu, Y. (2019) · RSC Advances · doi:10.1039/c9ra02258a · Cited by 11

Integrating radiomics into clinical trial design

Waninger, J. J., Green, M. D., Rest, C. C. L., Rosen, B., & Naqa, I. E. (2019) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.19.03217-5 · Cited by 11

Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival

Sallabanda, M., García-Berrocal, M. I., Romero, J., García-Jarabo, V., Exposito, M. J. J., Rincón, D. F. B., Zapata, I., & Magallón, M. R. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02321-x · Cited by 11

Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram

Friedes, C., Mai, N., Hazell, S. Z., Fu, W., Han, P., Bowers, M., Levy, B. P., Forde, P. M., Voong, K. R., & Hales, R. K. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.05.013 · Cited by 11

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases

Jiang, C. H., Kleber, T. J., Switchenko, J. M., & Khan, M. K. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01754-0 · Cited by 11

A nomogram for predicting brain metastases of EGFR-mutated lung adenocarcinoma patients and estimating the efficacy of therapeutic strategies

Wang, J., Zhang, B., Pang, Q., Zhang, T., Chen, X., Er, P., Wang, Y., You, J., & Wang, P. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1587 · Cited by 11

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987

Application of Prognostic Index Graded Prognostic Assessment(GPA) in Lung Cancer with Brain Metastases

Hai-guan, T. (2014) · Journal of Chinese Oncology · Cited by 1

A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment

Sperduto, C. M., Watanabe, Y., Mullan, J. C., Hood, T. W., Dyste, G. N., Watts, C. R., Bender, G. P., & Sperduto, P. W. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/12/s14 · Cited by 142

A validation study of graded prognostic assessment index for lung cancer patients with brain metastases.

Du, L., Venur, V. A., Dahiya, S., Garje, R., Osei-Boateng, K., Elson, P. J., Suh, J. H., Chao, S. T., & Ahluwalia, M. S. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2070 · Cited by 1

Application of New Prognostic Index GPA in Lung Cancer with Brain Metastases

Yao-xiong, X. (2012) · Kunming Yike Daxue xuebao